Status:
COMPLETED
An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Aortic Stenosis
Eligibility:
All Genders
45-85 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate whether treatment with an investigational drug as compared to placebo will reduce the risk of major cardiovascular events in patients with aortic stenosis.
Eligibility Criteria
Inclusion
- Patients aged 45 to 85 with mild abnormalities of the aortic valve as confirmed by an echocardiogram.
Exclusion
- Patients previously in a trial using the study drug, or currently taking any medications that are not allowed in this study.
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
1873 Patients enrolled
Trial Details
Trial ID
NCT00092677
Start Date
January 1 2001
End Date
April 1 2008
Last Update
May 16 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.